Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
CCHUGAI PHARMACEUTICAL CO.,LTD. logo
4519TSE Prime

CHUGAI PHARMACEUTICAL CO.,LTD.

中外製薬 Yahoo Finance

Recent & upcoming events

Jul 24
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
Jun 28
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Jun 25
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Apr 24
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Mar 25
Shareholder meeting 21:00
Shareholders' meeting
Venue: パレスホテル東京 2階「葵」 (Palace Hotel Tokyo, 2F Aoi), 東京都千代田区丸の内一丁目1番1号 Details
Add to Google Calendar
Jan 29
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Oct 27
Earnings 2:00 approx.
Q3 earnings announcement (scheduled)
Add to Google Calendar
Dec 27
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Dec 28
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
2027
Jan 29
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
Apr 30
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Jun 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Jun 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Jul 30
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥1.26T YoY +7.5%
Operating income ¥598.83B margin 47.6%
Net income ¥434.01B YoY +12.1%
EPS ¥264 YoY +12.0%
P/E —
ROE 22.1% Equity ratio 82% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q1FY26 Q1
Revenue ¥257.90B¥273.81B¥236.95B¥315.91B——
Operating income ¥106.69B¥121.58B¥99.87B¥158.32B——
Net income ¥77.57B¥91.21B¥74.40B¥111.86B——
Operating CF ¥120.03B¥117.72B¥110.14B¥168.53B——

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2020–2025）

国内機関 13.4%海外機関 65.6%未開示 21%202020212022202320242025
国内機関海外機関未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

ROCHE HOLDING LTD（ 61.1%ROCHE HOLDING LTD（常任代理人 西村あさひ法律事務所）日本マスタートラスト信託銀行株式会社 8.6%日本マスタートラスト信託銀行株式会社（信託口）株式会社日本カストディ銀行（信託口） 3.5%株式会社日本カストディ銀行（信託口）202020212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
ROCHE HOLDING LTD 1,005,670,000 61.1% Yuho (EDINET)
日本マスタートラスト信託銀行株式会社（信託口） 141,887,000 8.6% Yuho (EDINET)
株式会社日本カストディ銀行（信託口） 58,185,000 3.5% Yuho (EDINET)
STATE STREET BANK AND TRUSTCOMPANY 505001 22,990,000 1.4% Yuho (EDINET)
THE CHASE MANHATTAN BANK, N.A. LONDON SECS LENDING OMNIBUS ACCOUNT 21,987,000 1.3% Yuho (EDINET)
JP MORGAN CHASE BANK 385864 12,191,000 0.7% Yuho (EDINET)
SMBC日興証券株式会社 11,197,000 0.7% Yuho (EDINET)
JP MORGAN CHASE BANK 385781 9,479,000 0.6% Yuho (EDINET)
住友生命保険相互会社 9,150,000 0.6% Yuho (EDINET)
HSBC HONG KONG-TREASURY SERVICES A/C ASIAN EQUITIES DERIVATIVES 7,499,000 0.5% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

5/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 17.6%
✓ Positive operating cash flow ¥386.28B
✓ ROA improved YoY 17.5% → 17.6%
✗ Operating CF exceeds net income (accrual quality) OCF ¥386.28B / net income ¥434.01B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 86.1% → 82.1%
✗ Current ratio improved 5.53× → 4.23×
✓ No dilution (shares outstanding did not increase) 1,679,057,667 → 1,679,057,667
✓ Gross margin improved 71.0% → 71.1%
✗ Asset turnover improved 0.53× → 0.51×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 82.1%
Current ratio 4.2×
Years of positive operating CF 10 of last 10 yrs
Payout ratio 112%
Latest fiscal year result Profit (net income ¥434.01B)

Performance history

Last 10 years
0.0兆円0.3兆円0.6兆円0.9兆円1.3兆円 FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 4,9185,3425,7986,8627,8699,99812,59911,11411,70612,579
Operating income ———2,1063,0124,2195,3334,3925,4205,988
Ordinary income ——————————
Net income 5367279251,5762,1473,0303,7443,2553,8734,340
Total assets 8,0638,5259,19510,58912,35515,38718,69819,32522,08424,686
Equity ——————————

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

*Split-adjustedUnit: ¥100M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS ¥33¥44¥56¥96¥131¥184¥228¥198¥235¥264
ROE 8.4%10.9%12.8%19.6%23.4%28.0%28.7%21.3%22.0%22.1%
Operating CF 3881,0761,1912,0662,0502,7962,4414,0994,4763,863
Investing CF -101-367-741-817-983-1,189-1,460-373-2,274-2,013
Financing CF -334-296-350-669-995-1,074-1,456-1,393-1,410-3,079
FCF 2877094501,2491,0671,6079813,7262,2021,850

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

High ROE ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data